ResApp Health, now a subsidiary of Pfizer, Inc.

Instantly diagnose and manage respiratory disease using only a smartphone.

We provide point of care diagnostic solutions for telehealth that are easily integrated into existing platforms. We are working on apps to provide instant clinical quality diagnostic tests and management tools directly to consumers and healthcare providers.

ResAppDx is CE Marked in Europe and ARTG Listed in Australia.

See how ResApp improves telehealth

A world-leading technology platform

Over the last five years the research team, led by Associate Professor Udantha Abeyratne at The University of Queensland, has pioneered algorithms that accurately characterise the state of patients’ respiratory tracts. The team has created a powerful platform for respiratory disease diagnosis and management which only requires the sound of the patient’s cough or breathing and does not require physical contact. With the high quality microphones in today’s smartphones the platform can be delivered without the need for additional hardware.

ResApp Logo White

ResApp Health Limited

ABN 51 094 468 318

138 Juliette Street

Greenslopes, QLD 4120, Australia

© 2023 ResApp Health Limited. All rights reserved.